Globe Life (NYSE:GL) Issues Quarterly Earnings Results, Misses Expectations By $0.06 EPS

Globe Life (NYSE:GL) posted its quarterly earnings results on Wednesday. The company reported $3.61 EPS for the quarter, missing analysts’ consensus estimates of $3.67 by ($0.06), Zacks reports. Globe Life had a return on equity of 20.73% and a net margin of 19.58%.The business had revenue of $1.60 billion during the quarter, compared to analysts’ expectations of $1.59 billion. During the same period in the prior year, the firm posted $3.05 earnings per share. The firm’s revenue for the quarter was up 8.0% on a year-over-year basis. Globe Life updated its FY 2026 guidance to 15.550-15.950 EPS.

Globe Life Price Performance

Globe Life stock opened at $170.65 on Friday. Globe Life has a 52-week low of $123.00 and a 52-week high of $191.55. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.38. The firm’s fifty day moving average is $168.70 and its 200 day moving average is $152.76. The company has a market cap of $13.25 billion, a price-to-earnings ratio of 11.33 and a beta of 0.47.

Globe Life Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Monday, July 6th will be paid a dividend of $0.33 per share. The ex-dividend date of this dividend is Monday, July 6th. This represents a $1.32 dividend on an annualized basis and a yield of 0.8%. Globe Life’s dividend payout ratio is presently 9.13%.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on GL. Morgan Stanley lifted their price objective on shares of Globe Life from $181.00 to $208.00 and gave the company an “overweight” rating in a research report on Monday, July 6th. Keefe, Bruyette & Woods raised their target price on shares of Globe Life from $180.00 to $192.00 and gave the company an “outperform” rating in a research note on Monday, July 13th. Wells Fargo & Company boosted their price target on shares of Globe Life from $172.00 to $193.00 and gave the stock an “overweight” rating in a research note on Thursday, July 9th. Weiss Ratings downgraded shares of Globe Life from a “buy (b)” rating to a “buy (b-)” rating in a report on Monday. Finally, JPMorgan Chase & Co. raised their price objective on Globe Life from $181.00 to $201.00 and gave the company an “overweight” rating in a research report on Tuesday. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $187.60.

Globe Life News Summary

Here are the key news stories impacting Globe Life this week:

• Positive Sentiment: TD Cowen raised its price target on Globe Life to $225 from $215 and reiterated a buy rating, signaling confidence in further upside. Globe Life (NYSE:GL) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says
• Positive Sentiment: Globe Life lifted its full-year 2026 EPS guidance to $15.55-$15.95 and increased planned share repurchases to $670 million-$700 million, which supports earnings and shareholder return optimism. Globe Life projects 2026 net operating EPS of $15.55-$15.95 while lifting share repurchases to $670M-$700M
• Neutral Sentiment: The earnings call transcript and post-earnings commentary highlighted a mix of solid underwriting/investment income trends and ongoing headwinds, suggesting the quarter was good but not enough to reaccelerate the stock. Full Transcript: Globe Life Q2 2026 Earnings Call
• Neutral Sentiment: Revenue growth was in line to slightly ahead of expectations, with Q2 sales rising 7%-8% year over year, reinforcing that the core business remains resilient. Insurer Globe Life’s second-quarter profit rises on strong underwriting income
• Negative Sentiment: The stock fell after investors reacted to the EPS miss and reports that softer sales disappointed relative to expectations, outweighing the revenue beat. Globe Life Q2 earnings beat isn’t enough: Shares fall 7% as soft sales disappoint

Insider Buying and Selling at Globe Life

In other Globe Life news, CEO James Matthew Darden sold 4,663 shares of the business’s stock in a transaction that occurred on Tuesday, April 28th. The stock was sold at an average price of $153.88, for a total transaction of $717,542.44. Following the sale, the chief executive officer directly owned 58,451 shares of the company’s stock, valued at $8,994,439.88. The trade was a 7.39% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Frank M. Svoboda sold 20,000 shares of the firm’s stock in a transaction that occurred on Friday, May 22nd. The shares were sold at an average price of $156.68, for a total value of $3,133,600.00. Following the completion of the sale, the chief executive officer directly owned 54,020 shares of the company’s stock, valued at $8,463,853.60. The trade was a 27.02% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 90,187 shares of company stock valued at $14,299,874. Corporate insiders own 2.11% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of GL. Transamerica Financial Advisors LLC grew its stake in shares of Globe Life by 46.0% during the fourth quarter. Transamerica Financial Advisors LLC now owns 543 shares of the company’s stock valued at $76,000 after buying an additional 171 shares during the last quarter. AlphaCentric Advisors LLC bought a new stake in shares of Globe Life during the 4th quarter worth approximately $118,000. NorthRock Partners LLC bought a new stake in shares of Globe Life during the 3rd quarter worth approximately $208,000. Harvest Fund Management Co. Ltd boosted its holdings in Globe Life by 755.0% during the 3rd quarter. Harvest Fund Management Co. Ltd now owns 1,026 shares of the company’s stock valued at $147,000 after acquiring an additional 906 shares during the period. Finally, Johnson Financial Group Inc. boosted its holdings in Globe Life by 272.6% during the 3rd quarter. Johnson Financial Group Inc. now owns 734 shares of the company’s stock valued at $105,000 after acquiring an additional 537 shares during the period. 81.61% of the stock is owned by hedge funds and other institutional investors.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.